

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 4.69225195 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.69225195 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.65571446 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.65571446 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.49648678 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.45854689 |
| 7 | valine metabolic process (GO:0006573) | 4.38526848 |
| 8 | low-density lipoprotein particle clearance (GO:0034383) | 4.21855653 |
| 9 | gonadal mesoderm development (GO:0007506) | 4.21176385 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 4.06481357 |
| 11 | complement activation, alternative pathway (GO:0006957) | 4.03220416 |
| 12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.94333062 |
| 13 | protein carboxylation (GO:0018214) | 3.94333062 |
| 14 | cysteine metabolic process (GO:0006534) | 3.93683150 |
| 15 | plasma lipoprotein particle clearance (GO:0034381) | 3.88086762 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 3.86853130 |
| 17 | Golgi transport vesicle coating (GO:0048200) | 3.82271793 |
| 18 | COPI coating of Golgi vesicle (GO:0048205) | 3.82271793 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.74310114 |
| 20 | regulation of triglyceride catabolic process (GO:0010896) | 3.74274087 |
| 21 | lysine catabolic process (GO:0006554) | 3.69212592 |
| 22 | lysine metabolic process (GO:0006553) | 3.69212592 |
| 23 | regulation of protein activation cascade (GO:2000257) | 3.60296862 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 3.55851120 |
| 25 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.53320917 |
| 26 | regulation of complement activation (GO:0030449) | 3.48210570 |
| 27 | reverse cholesterol transport (GO:0043691) | 3.48190796 |
| 28 | COPII vesicle coating (GO:0048208) | 3.46983713 |
| 29 | glyoxylate metabolic process (GO:0046487) | 3.45420941 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 3.44031949 |
| 31 | regulation of cholesterol homeostasis (GO:2000188) | 3.39527387 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.38835240 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.38835240 |
| 34 | bile acid biosynthetic process (GO:0006699) | 3.36379200 |
| 35 | kynurenine metabolic process (GO:0070189) | 3.32359475 |
| 36 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.29834275 |
| 37 | urea cycle (GO:0000050) | 3.28014654 |
| 38 | urea metabolic process (GO:0019627) | 3.28014654 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 3.27950372 |
| 40 | macromolecular complex remodeling (GO:0034367) | 3.27950372 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 3.27950372 |
| 42 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.27771134 |
| 43 | 4-hydroxyproline metabolic process (GO:0019471) | 3.27701564 |
| 44 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.27387595 |
| 45 | homocysteine metabolic process (GO:0050667) | 3.25687444 |
| 46 | cellular modified amino acid catabolic process (GO:0042219) | 3.24353635 |
| 47 | tryptophan catabolic process (GO:0006569) | 3.21413211 |
| 48 | indole-containing compound catabolic process (GO:0042436) | 3.21413211 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 3.21413211 |
| 50 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.20857230 |
| 51 | triglyceride homeostasis (GO:0070328) | 3.20359232 |
| 52 | acylglycerol homeostasis (GO:0055090) | 3.20359232 |
| 53 | fatty acid beta-oxidation (GO:0006635) | 3.18925953 |
| 54 | phospholipid efflux (GO:0033700) | 3.18850715 |
| 55 | tricarboxylic acid metabolic process (GO:0072350) | 3.16129205 |
| 56 | regulation of cholesterol storage (GO:0010885) | 3.14488519 |
| 57 | fatty acid oxidation (GO:0019395) | 3.13064789 |
| 58 | plasma lipoprotein particle assembly (GO:0034377) | 3.11275886 |
| 59 | lipoprotein metabolic process (GO:0042157) | 3.10572475 |
| 60 | lipid oxidation (GO:0034440) | 3.10087671 |
| 61 | tryptophan metabolic process (GO:0006568) | 3.10041168 |
| 62 | ER overload response (GO:0006983) | 3.09563332 |
| 63 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.09383444 |
| 64 | regulation of fibrinolysis (GO:0051917) | 3.08755797 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 3.08533122 |
| 66 | protein-lipid complex assembly (GO:0065005) | 3.08435427 |
| 67 | protein localization to endosome (GO:0036010) | 3.08128728 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 3.07690422 |
| 69 | ethanol oxidation (GO:0006069) | 3.06746983 |
| 70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.06111307 |
| 71 | complement activation (GO:0006956) | 3.04624943 |
| 72 | nitrogen cycle metabolic process (GO:0071941) | 3.04168089 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 3.02851117 |
| 74 | complement activation, classical pathway (GO:0006958) | 3.01608874 |
| 75 | regulation of triglyceride metabolic process (GO:0090207) | 3.00279857 |
| 76 | tyrosine metabolic process (GO:0006570) | 3.00267984 |
| 77 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.00196434 |
| 78 | short-chain fatty acid metabolic process (GO:0046459) | 2.97574675 |
| 79 | bile acid metabolic process (GO:0008206) | 2.97492570 |
| 80 | proline biosynthetic process (GO:0006561) | 2.97218716 |
| 81 | fatty acid catabolic process (GO:0009062) | 2.97043730 |
| 82 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.96385428 |
| 83 | regulation of cholesterol metabolic process (GO:0090181) | 2.96130379 |
| 84 | pentose-phosphate shunt (GO:0006098) | 2.90269185 |
| 85 | cholesterol efflux (GO:0033344) | 2.89841686 |
| 86 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.88308878 |
| 87 | acetyl-CoA metabolic process (GO:0006084) | 2.87937811 |
| 88 | aromatic amino acid family metabolic process (GO:0009072) | 2.87755647 |
| 89 | negative regulation of sterol transport (GO:0032372) | 2.87245553 |
| 90 | negative regulation of cholesterol transport (GO:0032375) | 2.87245553 |
| 91 | plasma lipoprotein particle organization (GO:0071827) | 2.87242480 |
| 92 | protein-lipid complex subunit organization (GO:0071825) | 2.87143724 |
| 93 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.86979490 |
| 94 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.85973045 |
| 95 | coenzyme catabolic process (GO:0009109) | 2.85455779 |
| 96 | hepatocyte apoptotic process (GO:0097284) | 2.85361547 |
| 97 | positive regulation of fatty acid oxidation (GO:0046321) | 2.85076740 |
| 98 | vesicle coating (GO:0006901) | 2.84705385 |
| 99 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.84028802 |
| 100 | regulation of sequestering of triglyceride (GO:0010889) | 2.83326919 |
| 101 | branched-chain amino acid metabolic process (GO:0009081) | 2.82927146 |
| 102 | serine family amino acid catabolic process (GO:0009071) | 2.82733779 |
| 103 | phospholipid homeostasis (GO:0055091) | 2.82707637 |
| 104 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.82417939 |
| 105 | apoptotic cell clearance (GO:0043277) | 2.82363487 |
| 106 | intestinal cholesterol absorption (GO:0030299) | 2.81880272 |
| 107 | protein retention in ER lumen (GO:0006621) | 2.81439020 |
| 108 | protein activation cascade (GO:0072376) | 2.81319520 |
| 109 | low-density lipoprotein particle remodeling (GO:0034374) | 2.79663352 |
| 110 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 2.76027334 |
| 111 | NIK/NF-kappaB signaling (GO:0038061) | 2.74791009 |
| 112 | * ER-nucleus signaling pathway (GO:0006984) | 2.72196650 |
| 113 | positive regulation of nuclease activity (GO:0032075) | 2.70818238 |
| 114 | mannose metabolic process (GO:0006013) | 2.69267772 |
| 115 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.66114966 |
| 116 | negative regulation of necroptotic process (GO:0060546) | 2.65114085 |
| 117 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.64565010 |
| 118 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.62555801 |
| 119 | amyloid precursor protein catabolic process (GO:0042987) | 2.61770532 |
| 120 | cell adhesion mediated by integrin (GO:0033627) | 2.61256269 |
| 121 | regulation of metalloenzyme activity (GO:0048552) | 2.60859020 |
| 122 | membrane raft organization (GO:0031579) | 2.59036186 |
| 123 | membrane budding (GO:0006900) | 2.57775233 |
| 124 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.57246227 |
| 125 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.56875160 |
| 126 | hemidesmosome assembly (GO:0031581) | 2.56765587 |
| 127 | * cellular response to unfolded protein (GO:0034620) | 2.54554207 |
| 128 | desmosome organization (GO:0002934) | 2.52546524 |
| 129 | regulation of nuclease activity (GO:0032069) | 2.52349458 |
| 130 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.50278385 |
| 131 | pinocytosis (GO:0006907) | 2.48838093 |
| 132 | regulation of vitamin metabolic process (GO:0030656) | 2.44192206 |
| 133 | regulation of histone H3-K27 methylation (GO:0061085) | 2.42449613 |
| 134 | skin morphogenesis (GO:0043589) | 2.41960464 |
| 135 | regulation of necroptotic process (GO:0060544) | 2.38249034 |
| 136 | NADH metabolic process (GO:0006734) | 2.36299485 |
| 137 | regulation of defense response to virus by virus (GO:0050690) | 2.34462355 |
| 138 | mammary gland epithelial cell proliferation (GO:0033598) | 2.32726840 |
| 139 | interferon-gamma secretion (GO:0072643) | 2.32000217 |
| 140 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.31306499 |
| 141 | embryonic process involved in female pregnancy (GO:0060136) | 2.30288571 |
| 142 | sphingosine metabolic process (GO:0006670) | 2.29820717 |
| 143 | response to peptidoglycan (GO:0032494) | 2.29562262 |
| 144 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.29082321 |
| 145 | localization within membrane (GO:0051668) | 2.26724555 |
| 146 | peptidyl-asparagine modification (GO:0018196) | 2.26578696 |
| 147 | * cellular response to topologically incorrect protein (GO:0035967) | 2.26420317 |
| 148 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.25890243 |
| 149 | intestinal epithelial cell development (GO:0060576) | 2.25749820 |
| 150 | hypotonic response (GO:0006971) | 2.25723814 |
| 151 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.25229455 |
| 152 | * response to endoplasmic reticulum stress (GO:0034976) | 2.24162812 |
| 153 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.21945709 |
| 154 | hyaluronan catabolic process (GO:0030214) | 2.21879873 |
| 155 | amyloid precursor protein metabolic process (GO:0042982) | 2.21736001 |
| 156 | protein N-linked glycosylation (GO:0006487) | 2.20516670 |
| 157 | regulation of necrotic cell death (GO:0010939) | 2.17616800 |
| 158 | membrane protein ectodomain proteolysis (GO:0006509) | 2.16675712 |
| 159 | ribosome assembly (GO:0042255) | 2.13185065 |
| 160 | formation of translation preinitiation complex (GO:0001731) | 2.13123676 |
| 161 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.12673016 |
| 162 | type I interferon signaling pathway (GO:0060337) | 2.12341586 |
| 163 | cellular response to type I interferon (GO:0071357) | 2.12341586 |
| 164 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.11590279 |
| 165 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.11524603 |
| 166 | regulation of response to interferon-gamma (GO:0060330) | 2.10477382 |
| 167 | response to thyroid hormone (GO:0097066) | 2.09764610 |
| 168 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.09239157 |
| 169 | response to type I interferon (GO:0034340) | 2.08460477 |
| 170 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.08420491 |
| 171 | diol metabolic process (GO:0034311) | 2.08245419 |
| 172 | glycosphingolipid catabolic process (GO:0046479) | 2.07227315 |
| 173 | iron ion import (GO:0097286) | 2.07121631 |
| 174 | programmed necrotic cell death (GO:0097300) | 2.06814799 |
| 175 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.06131012 |
| 176 | proline metabolic process (GO:0006560) | 2.04794580 |
| 177 | regulation of keratinocyte differentiation (GO:0045616) | 2.04459206 |
| 178 | necroptotic process (GO:0070266) | 2.04114778 |
| 179 | N-acetylneuraminate metabolic process (GO:0006054) | 2.02946692 |
| 180 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.02074781 |
| 181 | protein maturation by protein folding (GO:0022417) | 2.01621599 |
| 182 | myeloid dendritic cell differentiation (GO:0043011) | 2.01545136 |
| 183 | barbed-end actin filament capping (GO:0051016) | 2.01371949 |
| 184 | positive regulation of pseudopodium assembly (GO:0031274) | 1.99670526 |
| 185 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 1.98152181 |
| 186 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 1.97300046 |
| 187 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 1.97218002 |
| 188 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 1.96823994 |
| 189 | stress fiber assembly (GO:0043149) | 1.96020313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.16830374 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.69552968 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.19194830 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.67129495 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.04224208 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.26904238 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.11904255 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.07669524 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.96682251 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.91990811 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.64362999 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.60376144 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.48678676 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.29032720 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.25977640 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.24025143 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10051050 |
| 18 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.05169946 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.99778079 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.98176532 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86517550 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.83641966 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81582676 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80078234 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.65514367 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64905732 |
| 27 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.62914625 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61056888 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60352803 |
| 30 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59677149 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.58609330 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56727886 |
| 33 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.55702440 |
| 34 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.55702440 |
| 35 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.55478934 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52623065 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52440725 |
| 38 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47451578 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.46504062 |
| 40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46285799 |
| 41 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.45744825 |
| 42 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.44761980 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.44192196 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43880219 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.43318609 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43089215 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42684701 |
| 48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42441978 |
| 49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42317165 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41995222 |
| 51 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.39175739 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38136223 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.37368953 |
| 54 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.37110010 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36692888 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35575680 |
| 57 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.35148075 |
| 58 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.31437719 |
| 59 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31291911 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30234267 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29617001 |
| 62 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.29407968 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29101003 |
| 64 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.29028699 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27886971 |
| 66 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24628073 |
| 67 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24528228 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24255210 |
| 69 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23790673 |
| 70 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23707496 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23191859 |
| 72 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20803180 |
| 73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20347386 |
| 74 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18773913 |
| 75 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18498940 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17638472 |
| 77 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16890196 |
| 78 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16861058 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16068127 |
| 80 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.15763221 |
| 81 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15522289 |
| 82 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.13931193 |
| 83 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13006142 |
| 84 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.12962821 |
| 85 | MYC_22102868_ChIP-Seq_BL_Human | 1.10020786 |
| 86 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10003806 |
| 87 | MAF_26560356_Chip-Seq_TH1_Human | 1.09309934 |
| 88 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.08868862 |
| 89 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07523817 |
| 90 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07461479 |
| 91 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.07415409 |
| 92 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07265912 |
| 93 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06137918 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05752840 |
| 95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05751068 |
| 96 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.05714639 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04928956 |
| 98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03678855 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03395637 |
| 100 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.03308447 |
| 101 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03258846 |
| 102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03087640 |
| 103 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.03077006 |
| 104 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.03021332 |
| 105 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02616111 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02333611 |
| 107 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02014378 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98839863 |
| 109 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98225842 |
| 110 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97894564 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96988176 |
| 112 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96594525 |
| 113 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96134369 |
| 114 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94325453 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93954192 |
| 116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93046021 |
| 117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92507681 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92316439 |
| 119 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91007950 |
| 120 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90239616 |
| 121 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90090990 |
| 122 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89143453 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88903748 |
| 124 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87469010 |
| 125 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87209342 |
| 126 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85385862 |
| 127 | MYB_26560356_Chip-Seq_TH2_Human | 0.85319717 |
| 128 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84966912 |
| 129 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84212429 |
| 130 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.83627280 |
| 131 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.83387183 |
| 132 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83134159 |
| 133 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82160972 |
| 134 | MYB_26560356_Chip-Seq_TH1_Human | 0.82006281 |
| 135 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81596543 |
| 136 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81436141 |
| 137 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.81322727 |
| 138 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80058156 |
| 139 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78727965 |
| 140 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78667514 |
| 141 | SPI1_23127762_ChIP-Seq_K562_Human | 0.78369043 |
| 142 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78013676 |
| 143 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.77735968 |
| 144 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.77604951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.86667612 |
| 2 | MP0005360_urolithiasis | 4.17912047 |
| 3 | MP0005365_abnormal_bile_salt | 3.69017886 |
| 4 | MP0009840_abnormal_foam_cell | 3.56884773 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.30104276 |
| 6 | MP0010329_abnormal_lipoprotein_level | 2.79114161 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.70459312 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.58234195 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.54380568 |
| 10 | MP0003252_abnormal_bile_duct | 2.51280143 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.41798081 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.40533159 |
| 13 | MP0005670_abnormal_white_adipose | 2.21031304 |
| 14 | MP0005083_abnormal_biliary_tract | 2.20726945 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.20066637 |
| 16 | MP0003195_calcinosis | 2.19479700 |
| 17 | MP0005451_abnormal_body_composition | 2.16981157 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 2.08958377 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.04079696 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.01713174 |
| 21 | MP0004782_abnormal_surfactant_physiolog | 1.96223841 |
| 22 | MP0000609_abnormal_liver_physiology | 1.95114030 |
| 23 | MP0002796_impaired_skin_barrier | 1.92112070 |
| 24 | MP0005332_abnormal_amino_acid | 1.89971760 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.84707968 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.83043609 |
| 27 | MP0000858_altered_metastatic_potential | 1.81827491 |
| 28 | MP0002877_abnormal_melanocyte_morpholog | 1.76659769 |
| 29 | MP0003453_abnormal_keratinocyte_physiol | 1.75313796 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.72297360 |
| 31 | MP0004233_abnormal_muscle_weight | 1.64657927 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.60670418 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.59837964 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.59155175 |
| 35 | MP0004130_abnormal_muscle_cell | 1.56364682 |
| 36 | MP0010352_gastrointestinal_tract_polyps | 1.52429138 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.50180073 |
| 38 | MP0001216_abnormal_epidermal_layer | 1.49592737 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.49280673 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.46308217 |
| 41 | MP0000604_amyloidosis | 1.45787743 |
| 42 | MP0003436_decreased_susceptibility_to | 1.44860430 |
| 43 | MP0005501_abnormal_skin_physiology | 1.44849818 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.42378682 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.40849869 |
| 46 | MP0003186_abnormal_redox_activity | 1.39611265 |
| 47 | MP0003868_abnormal_feces_composition | 1.38331710 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.38262971 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.36427969 |
| 50 | MP0001873_stomach_inflammation | 1.35128605 |
| 51 | MP0008260_abnormal_autophagy | 1.33777378 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.32059247 |
| 53 | MP0006054_spinal_hemorrhage | 1.31649299 |
| 54 | MP0003724_increased_susceptibility_to | 1.30120084 |
| 55 | MP0003221_abnormal_cardiomyocyte_apopto | 1.29991513 |
| 56 | MP0005275_abnormal_skin_tensile | 1.27468211 |
| 57 | MP0004019_abnormal_vitamin_homeostasis | 1.26240226 |
| 58 | MP0003091_abnormal_cell_migration | 1.25257120 |
| 59 | MP0002971_abnormal_brown_adipose | 1.25084169 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.24833466 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 1.24748486 |
| 62 | MP0001800_abnormal_humoral_immune | 1.23926787 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.22867340 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.19389962 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.16457109 |
| 66 | MP0008469_abnormal_protein_level | 1.16279266 |
| 67 | MP0002254_reproductive_system_inflammat | 1.15796907 |
| 68 | MP0003828_pulmonary_edema | 1.15362862 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 1.14682578 |
| 70 | MP0000013_abnormal_adipose_tissue | 1.14484356 |
| 71 | MP0000598_abnormal_liver_morphology | 1.13836933 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.12357829 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 1.11844519 |
| 74 | MP0002723_abnormal_immune_serum | 1.11123697 |
| 75 | MP0005334_abnormal_fat_pad | 1.10443659 |
| 76 | MP0001727_abnormal_embryo_implantation | 1.08294240 |
| 77 | MP0000685_abnormal_immune_system | 1.07378638 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 1.06862129 |
| 79 | MP0002332_abnormal_exercise_endurance | 1.06398731 |
| 80 | MP0009764_decreased_sensitivity_to | 1.05533231 |
| 81 | MP0000627_abnormal_mammary_gland | 1.04248398 |
| 82 | MP0002420_abnormal_adaptive_immunity | 1.03769702 |
| 83 | MP0001819_abnormal_immune_cell | 1.03610023 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 1.03475605 |
| 85 | MP0002006_tumorigenesis | 1.01872080 |
| 86 | MP0001835_abnormal_antigen_presentation | 1.01031205 |
| 87 | MP0003448_altered_tumor_morphology | 1.00175247 |
| 88 | MP0002419_abnormal_innate_immunity | 0.99420142 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.99345118 |
| 90 | MP0009763_increased_sensitivity_to | 0.99330133 |
| 91 | MP0001851_eye_inflammation | 0.98443275 |
| 92 | MP0000490_abnormal_crypts_of | 0.97887519 |
| 93 | MP0004510_myositis | 0.96314122 |
| 94 | MP0004947_skin_inflammation | 0.96016394 |
| 95 | MP0006082_CNS_inflammation | 0.95213871 |
| 96 | MP0001881_abnormal_mammary_gland | 0.95114709 |
| 97 | MP0003690_abnormal_glial_cell | 0.94668128 |
| 98 | MP0001756_abnormal_urination | 0.94643734 |
| 99 | MP0001944_abnormal_pancreas_morphology | 0.93811784 |
| 100 | MP0002398_abnormal_bone_marrow | 0.93497444 |
| 101 | MP0001845_abnormal_inflammatory_respons | 0.91813686 |
| 102 | MP0003075_altered_response_to | 0.91641455 |
| 103 | MP0003303_peritoneal_inflammation | 0.90881003 |
| 104 | MP0003329_amyloid_beta_deposits | 0.90594547 |
| 105 | MP0005023_abnormal_wound_healing | 0.89642780 |
| 106 | MP0001764_abnormal_homeostasis | 0.88425163 |
| 107 | MP0005165_increased_susceptibility_to | 0.87199516 |
| 108 | MP0002098_abnormal_vibrissa_morphology | 0.86780493 |
| 109 | MP0002166_altered_tumor_susceptibility | 0.86728741 |
| 110 | MP0002722_abnormal_immune_system | 0.86625658 |
| 111 | MP0003279_aneurysm | 0.86242897 |
| 112 | MP0004957_abnormal_blastocyst_morpholog | 0.86217098 |
| 113 | MP0001243_abnormal_dermal_layer | 0.85773306 |
| 114 | MP0000716_abnormal_immune_system | 0.85623079 |
| 115 | MP0005025_abnormal_response_to | 0.85525876 |
| 116 | MP0001853_heart_inflammation | 0.85363811 |
| 117 | MP0005387_immune_system_phenotype | 0.85212696 |
| 118 | MP0001790_abnormal_immune_system | 0.85212696 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.85135798 |
| 120 | MP0005408_hypopigmentation | 0.84753510 |
| 121 | MP0009785_altered_susceptibility_to | 0.84312753 |
| 122 | MP0005621_abnormal_cell_physiology | 0.84236797 |
| 123 | MP0002396_abnormal_hematopoietic_system | 0.84108342 |
| 124 | MP0002693_abnormal_pancreas_physiology | 0.83937902 |
| 125 | MP0002405_respiratory_system_inflammati | 0.83642283 |
| 126 | MP0005671_abnormal_response_to | 0.83539654 |
| 127 | MP0002909_abnormal_adrenal_gland | 0.83308196 |
| 128 | MP0010368_abnormal_lymphatic_system | 0.81928484 |
| 129 | MP0009931_abnormal_skin_appearance | 0.81829067 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.81508197 |
| 131 | MP0000689_abnormal_spleen_morphology | 0.80958647 |
| 132 | MP0000003_abnormal_adipose_tissue | 0.80315807 |
| 133 | MP0000343_altered_response_to | 0.80254789 |
| 134 | MP0005257_abnormal_intraocular_pressure | 0.78896436 |
| 135 | MP0009115_abnormal_fat_cell | 0.77939835 |
| 136 | MP0010678_abnormal_skin_adnexa | 0.77911317 |
| 137 | MP0005535_abnormal_body_temperature | 0.77386606 |
| 138 | MP0002429_abnormal_blood_cell | 0.77119708 |
| 139 | MP0002060_abnormal_skin_morphology | 0.75290875 |
| 140 | MP0002837_dystrophic_cardiac_calcinosis | 0.74025417 |
| 141 | MP0009780_abnormal_chondrocyte_physiolo | 0.72989048 |
| 142 | MP0002970_abnormal_white_adipose | 0.72782223 |
| 143 | MP0005000_abnormal_immune_tolerance | 0.72716226 |
| 144 | MP0004043_abnormal_pH_regulation | 0.71505238 |
| 145 | MP0006036_abnormal_mitochondrial_physio | 0.70916774 |
| 146 | MP0003183_abnormal_peptide_metabolism | 0.70800898 |
| 147 | MP0005164_abnormal_response_to | 0.70225556 |
| 148 | MP0001661_extended_life_span | 0.68768870 |
| 149 | MP0000249_abnormal_blood_vessel | 0.68259959 |
| 150 | MP0003959_abnormal_lean_body | 0.68158594 |
| 151 | MP0002998_abnormal_bone_remodeling | 0.67888146 |
| 152 | MP0010234_abnormal_vibrissa_follicle | 0.67788137 |
| 153 | MP0005448_abnormal_energy_balance | 0.65330121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Xanthomatosis (HP:0000991) | 4.68323753 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.48458451 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.30948138 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.05090831 |
| 5 | Complement deficiency (HP:0004431) | 4.04233654 |
| 6 | Hypoglycemic coma (HP:0001325) | 3.76583652 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.68182180 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.60212857 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 3.49994715 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.46865377 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.46865377 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.46865377 |
| 13 | Ketosis (HP:0001946) | 3.41908272 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.37388278 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.32817476 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 3.31661038 |
| 17 | Ketoacidosis (HP:0001993) | 3.20793096 |
| 18 | Mucopolysacchariduria (HP:0008155) | 3.20167004 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.20167004 |
| 20 | Abnormality of complement system (HP:0005339) | 3.18057918 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.07374279 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 3.06384831 |
| 23 | J-shaped sella turcica (HP:0002680) | 3.05496384 |
| 24 | Myocardial infarction (HP:0001658) | 3.01744704 |
| 25 | Hyperammonemia (HP:0001987) | 2.98574565 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 2.96867116 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.96209181 |
| 28 | Vertebral compression fractures (HP:0002953) | 2.94517190 |
| 29 | Hypolipoproteinemia (HP:0010981) | 2.88487570 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.86085585 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.86085585 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.86085585 |
| 33 | Joint hemorrhage (HP:0005261) | 2.82943752 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.80603040 |
| 35 | Hyperglycinuria (HP:0003108) | 2.75783410 |
| 36 | Hypoglycemic seizures (HP:0002173) | 2.73886040 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.71583002 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.70250933 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 2.69751132 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.69751132 |
| 41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.64846344 |
| 42 | Epidermoid cyst (HP:0200040) | 2.64096053 |
| 43 | Vacuolated lymphocytes (HP:0001922) | 2.62613475 |
| 44 | Right ventricular cardiomyopathy (HP:0011663) | 2.57120043 |
| 45 | Insidious onset (HP:0003587) | 2.55065362 |
| 46 | Termporal pattern (HP:0011008) | 2.55065362 |
| 47 | Late onset (HP:0003584) | 2.54298043 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.54091369 |
| 49 | Skin nodule (HP:0200036) | 2.52009122 |
| 50 | Loss of speech (HP:0002371) | 2.46863648 |
| 51 | Hydroxyprolinuria (HP:0003080) | 2.45405856 |
| 52 | Abnormality of proline metabolism (HP:0010907) | 2.45405856 |
| 53 | Acanthocytosis (HP:0001927) | 2.42119498 |
| 54 | Hyperglycinemia (HP:0002154) | 2.41715988 |
| 55 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.37829126 |
| 56 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.36107328 |
| 57 | Glomerulonephritis (HP:0000099) | 2.35128150 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.34856235 |
| 59 | Flat acetabular roof (HP:0003180) | 2.34746235 |
| 60 | Fat malabsorption (HP:0002630) | 2.34680548 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.34041136 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.30994320 |
| 63 | Abnormality of methionine metabolism (HP:0010901) | 2.28971607 |
| 64 | Tetraparesis (HP:0002273) | 2.24904382 |
| 65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24389707 |
| 66 | Fatigue (HP:0012378) | 2.23209795 |
| 67 | Osteolytic defects of the hand bones (HP:0009699) | 2.22976735 |
| 68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.22976735 |
| 69 | Sparse lateral eyebrow (HP:0005338) | 2.22528857 |
| 70 | Peritonitis (HP:0002586) | 2.21857173 |
| 71 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.19111759 |
| 72 | Menorrhagia (HP:0000132) | 2.19006473 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.18504745 |
| 74 | Distal lower limb muscle weakness (HP:0009053) | 2.16543992 |
| 75 | Amyloidosis (HP:0011034) | 2.15878418 |
| 76 | Generalized aminoaciduria (HP:0002909) | 2.13851037 |
| 77 | Protuberant abdomen (HP:0001538) | 2.10073953 |
| 78 | Hypertriglyceridemia (HP:0002155) | 2.08325661 |
| 79 | Global brain atrophy (HP:0002283) | 2.08323171 |
| 80 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.07657488 |
| 81 | Back pain (HP:0003418) | 2.07579823 |
| 82 | Hyperparathyroidism (HP:0000843) | 2.07127175 |
| 83 | Abnormality of oral frenula (HP:0000190) | 2.06211960 |
| 84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05878402 |
| 85 | Dicarboxylic aciduria (HP:0003215) | 2.05878402 |
| 86 | Distal lower limb amyotrophy (HP:0008944) | 2.05000384 |
| 87 | Gingival bleeding (HP:0000225) | 2.03629401 |
| 88 | Pancreatitis (HP:0001733) | 2.02266922 |
| 89 | Hepatocellular carcinoma (HP:0001402) | 2.01736839 |
| 90 | Growth hormone excess (HP:0000845) | 1.98158178 |
| 91 | Abnormal gallbladder morphology (HP:0012437) | 1.97368995 |
| 92 | Mitral stenosis (HP:0001718) | 1.97088365 |
| 93 | Achilles tendon contracture (HP:0001771) | 1.96996772 |
| 94 | Onycholysis (HP:0001806) | 1.96595742 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96404282 |
| 96 | Spinal cord lesions (HP:0100561) | 1.96128754 |
| 97 | Syringomyelia (HP:0003396) | 1.96128754 |
| 98 | Bone pain (HP:0002653) | 1.94908846 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 1.94725649 |
| 100 | Eczematoid dermatitis (HP:0000976) | 1.94507530 |
| 101 | Polycythemia (HP:0001901) | 1.94335212 |
| 102 | Autoimmune hemolytic anemia (HP:0001890) | 1.94235367 |
| 103 | Spondylolisthesis (HP:0003302) | 1.94177896 |
| 104 | Symptomatic seizures (HP:0011145) | 1.92184625 |
| 105 | Sensorimotor neuropathy (HP:0007141) | 1.92011605 |
| 106 | Cerebral aneurysm (HP:0004944) | 1.91914210 |
| 107 | Abnormality of nucleobase metabolism (HP:0010932) | 1.91025578 |
| 108 | Asymmetric septal hypertrophy (HP:0001670) | 1.90887517 |
| 109 | Oligomenorrhea (HP:0000876) | 1.90345188 |
| 110 | Hyperglycemia (HP:0003074) | 1.89369639 |
| 111 | Abnormality of the Achilles tendon (HP:0005109) | 1.89134464 |
| 112 | Cholelithiasis (HP:0001081) | 1.88896510 |
| 113 | Premature rupture of membranes (HP:0001788) | 1.88650398 |
| 114 | Myoglobinuria (HP:0002913) | 1.88625176 |
| 115 | Abnormal cartilage morphology (HP:0002763) | 1.88392210 |
| 116 | Insulin resistance (HP:0000855) | 1.87098177 |
| 117 | Increased serum ferritin (HP:0003281) | 1.86802790 |
| 118 | Elevated alkaline phosphatase (HP:0003155) | 1.85113276 |
| 119 | Thin bony cortex (HP:0002753) | 1.85041593 |
| 120 | Upper limb amyotrophy (HP:0009129) | 1.85004982 |
| 121 | Distal upper limb amyotrophy (HP:0007149) | 1.85004982 |
| 122 | Esophageal varix (HP:0002040) | 1.84994578 |
| 123 | Abnormality of macrophages (HP:0004311) | 1.84813139 |
| 124 | Protrusio acetabuli (HP:0003179) | 1.82994659 |
| 125 | Metabolic acidosis (HP:0001942) | 1.82989298 |
| 126 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.82728643 |
| 127 | Nail dystrophy (HP:0008404) | 1.82634457 |
| 128 | Curly hair (HP:0002212) | 1.81608273 |
| 129 | Autoamputation (HP:0001218) | 1.80265669 |
| 130 | Axonal loss (HP:0003447) | 1.80223556 |
| 131 | Interstitial pulmonary disease (HP:0006530) | 1.79889888 |
| 132 | Reduced antithrombin III activity (HP:0001976) | 1.79558992 |
| 133 | Hemorrhage of the eye (HP:0011885) | 1.78915734 |
| 134 | Nephritis (HP:0000123) | 1.77634851 |
| 135 | Cervical subluxation (HP:0003308) | 1.76597016 |
| 136 | Acute hepatic failure (HP:0006554) | 1.76512686 |
| 137 | Microglossia (HP:0000171) | 1.76430847 |
| 138 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76214590 |
| 139 | Conjugated hyperbilirubinemia (HP:0002908) | 1.75874418 |
| 140 | Spastic diplegia (HP:0001264) | 1.75104750 |
| 141 | Alopecia of scalp (HP:0002293) | 1.74839016 |
| 142 | Micronodular cirrhosis (HP:0001413) | 1.74381962 |
| 143 | Beaking of vertebral bodies (HP:0004568) | 1.73475643 |
| 144 | Gout (HP:0001997) | 1.72976149 |
| 145 | Abnormality of the thoracic spine (HP:0100711) | 1.72227926 |
| 146 | Entropion (HP:0000621) | 1.70417675 |
| 147 | Thoracic kyphosis (HP:0002942) | 1.70279158 |
| 148 | Microretrognathia (HP:0000308) | 1.68869613 |
| 149 | Chronic diarrhea (HP:0002028) | 1.68638728 |
| 150 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.67129149 |
| 151 | Deformed sella turcica (HP:0002681) | 1.66743868 |
| 152 | Spinal rigidity (HP:0003306) | 1.65862785 |
| 153 | Hand muscle atrophy (HP:0009130) | 1.65602120 |
| 154 | Atrophic scars (HP:0001075) | 1.64903942 |
| 155 | Upper limb muscle weakness (HP:0003484) | 1.64237765 |
| 156 | Short nail (HP:0001799) | 1.62860126 |
| 157 | Coarse hair (HP:0002208) | 1.61375473 |
| 158 | Erythema (HP:0010783) | 1.59168200 |
| 159 | Thick nail (HP:0001805) | 1.58949274 |
| 160 | Increased IgM level (HP:0003496) | 1.58812764 |
| 161 | Increased connective tissue (HP:0009025) | 1.58786916 |
| 162 | Abnormality of the gastric mucosa (HP:0004295) | 1.58123532 |
| 163 | Ridged nail (HP:0001807) | 1.57440121 |
| 164 | Hepatosplenomegaly (HP:0001433) | 1.57311765 |
| 165 | Ankyloglossia (HP:0010296) | 1.56583774 |
| 166 | Abdominal distention (HP:0003270) | 1.56548439 |
| 167 | Ragged-red muscle fibers (HP:0003200) | 1.56076484 |
| 168 | Abnormal gallbladder physiology (HP:0012438) | 1.55685341 |
| 169 | Cholecystitis (HP:0001082) | 1.55685341 |
| 170 | Absent frontal sinuses (HP:0002688) | 1.55224939 |
| 171 | T lymphocytopenia (HP:0005403) | 1.54334579 |
| 172 | Severe short stature (HP:0003510) | 1.54199962 |
| 173 | Progressive neurologic deterioration (HP:0002344) | 1.54081016 |
| 174 | Abnormal foot bone ossification (HP:0010675) | 1.53659713 |
| 175 | Gastrointestinal stroma tumor (HP:0100723) | 1.53033714 |
| 176 | Urticaria (HP:0001025) | 1.51201362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.32681074 |
| 2 | TRIB3 | 4.79603498 |
| 3 | BCKDK | 3.41701707 |
| 4 | PKN2 | 3.10769220 |
| 5 | SIK1 | 2.72861580 |
| 6 | TAOK3 | 2.66916266 |
| 7 | PRPF4B | 2.65715065 |
| 8 | EPHA2 | 2.65607838 |
| 9 | SIK3 | 2.37744474 |
| 10 | FLT3 | 2.37113816 |
| 11 | FGFR4 | 2.25215933 |
| 12 | CDK12 | 2.21984403 |
| 13 | TYK2 | 1.91232816 |
| 14 | TBK1 | 1.90124031 |
| 15 | INSRR | 1.89865662 |
| 16 | SCYL2 | 1.89520578 |
| 17 | TESK2 | 1.88038638 |
| 18 | TGFBR2 | 1.85927665 |
| 19 | EIF2AK1 | 1.85205880 |
| 20 | PTK6 | 1.75637730 |
| 21 | EPHB1 | 1.73493909 |
| 22 | TAOK2 | 1.71200371 |
| 23 | PIK3CG | 1.69475211 |
| 24 | MST1R | 1.65308251 |
| 25 | PIM2 | 1.60074236 |
| 26 | MAP3K10 | 1.54287661 |
| 27 | NME2 | 1.52938899 |
| 28 | IRAK3 | 1.51514714 |
| 29 | LRRK2 | 1.50198455 |
| 30 | RIPK1 | 1.48194184 |
| 31 | MATK | 1.47514047 |
| 32 | JAK1 | 1.47306039 |
| 33 | MAP4K1 | 1.43463452 |
| 34 | MET | 1.39439412 |
| 35 | EEF2K | 1.36989784 |
| 36 | CAMK1D | 1.36222302 |
| 37 | JAK3 | 1.29088941 |
| 38 | TTN | 1.24430678 |
| 39 | CSF1R | 1.23864077 |
| 40 | SMG1 | 1.22570868 |
| 41 | NEK9 | 1.20799662 |
| 42 | JAK2 | 1.20722486 |
| 43 | BMX | 1.17897768 |
| 44 | MAP3K3 | 1.17453471 |
| 45 | ZAP70 | 1.13085579 |
| 46 | FRK | 1.12684142 |
| 47 | MAP3K2 | 1.12498172 |
| 48 | ARAF | 1.10650040 |
| 49 | MAP2K3 | 1.10619382 |
| 50 | MAP3K6 | 1.09495948 |
| 51 | ICK | 1.09186932 |
| 52 | PDGFRA | 1.08033085 |
| 53 | KIT | 1.07820924 |
| 54 | RPS6KB2 | 1.02464772 |
| 55 | KDR | 1.02351465 |
| 56 | MAPK15 | 1.02330298 |
| 57 | IRAK4 | 0.90933114 |
| 58 | EPHA3 | 0.87850657 |
| 59 | ITK | 0.85803636 |
| 60 | CSK | 0.84760965 |
| 61 | STK10 | 0.84444225 |
| 62 | RET | 0.83153434 |
| 63 | MST4 | 0.82826439 |
| 64 | CDK8 | 0.81402071 |
| 65 | PBK | 0.80646409 |
| 66 | MAPK11 | 0.80294595 |
| 67 | PTK2 | 0.80005516 |
| 68 | MAP2K2 | 0.79429830 |
| 69 | GRK6 | 0.78031772 |
| 70 | HIPK2 | 0.77646911 |
| 71 | TAOK1 | 0.77251468 |
| 72 | IKBKE | 0.77115077 |
| 73 | MAP3K14 | 0.71372536 |
| 74 | BCR | 0.70777374 |
| 75 | ERBB3 | 0.70591320 |
| 76 | NEK6 | 0.70555312 |
| 77 | BTK | 0.69989421 |
| 78 | FGFR3 | 0.67693806 |
| 79 | MAPKAPK3 | 0.67522423 |
| 80 | MAP3K12 | 0.65795503 |
| 81 | EIF2AK2 | 0.65639766 |
| 82 | MAP3K1 | 0.64778785 |
| 83 | PRKAA2 | 0.63064471 |
| 84 | SRPK1 | 0.63038737 |
| 85 | MAP3K5 | 0.62641818 |
| 86 | CDK7 | 0.62369895 |
| 87 | IKBKB | 0.61400430 |
| 88 | CAMKK2 | 0.61377897 |
| 89 | DDR2 | 0.60684421 |
| 90 | CLK1 | 0.60361626 |
| 91 | TEC | 0.59204318 |
| 92 | YES1 | 0.59167566 |
| 93 | LMTK2 | 0.58544986 |
| 94 | DYRK1B | 0.58399841 |
| 95 | CDK6 | 0.57209943 |
| 96 | PASK | 0.57003253 |
| 97 | PRKG2 | 0.56853796 |
| 98 | MAP3K11 | 0.56736794 |
| 99 | ABL2 | 0.56697259 |
| 100 | GSK3A | 0.55578614 |
| 101 | CHUK | 0.55577900 |
| 102 | MAPKAPK2 | 0.55223749 |
| 103 | CAMK1G | 0.54054579 |
| 104 | BLK | 0.53156836 |
| 105 | PDPK1 | 0.52755399 |
| 106 | CDK4 | 0.52317539 |
| 107 | PRKCH | 0.51817551 |
| 108 | MAP2K1 | 0.51415880 |
| 109 | IRAK1 | 0.51329337 |
| 110 | MAP3K13 | 0.50708318 |
| 111 | RPS6KA4 | 0.49357791 |
| 112 | NTRK1 | 0.49197750 |
| 113 | KSR2 | 0.48604522 |
| 114 | PRKCI | 0.48581295 |
| 115 | IGF1R | 0.48581258 |
| 116 | PAK4 | 0.46483603 |
| 117 | HCK | 0.46438715 |
| 118 | TESK1 | 0.46233479 |
| 119 | PAK2 | 0.46216209 |
| 120 | ERBB4 | 0.45816661 |
| 121 | PRKD2 | 0.45110784 |
| 122 | CDK9 | 0.42700394 |
| 123 | EIF2AK3 | 0.41841929 |
| 124 | TRPM7 | 0.41530489 |
| 125 | EGFR | 0.40708013 |
| 126 | PDK1 | 0.40069886 |
| 127 | MAP3K7 | 0.39275858 |
| 128 | LATS2 | 0.38635848 |
| 129 | MTOR | 0.38165678 |
| 130 | PRKD1 | 0.37913563 |
| 131 | RIPK4 | 0.37834518 |
| 132 | LCK | 0.37446996 |
| 133 | LIMK1 | 0.36463188 |
| 134 | SYK | 0.36149455 |
| 135 | PDGFRB | 0.35603081 |
| 136 | LYN | 0.35301676 |
| 137 | TRIM28 | 0.34581892 |
| 138 | MAP3K8 | 0.33751098 |
| 139 | STK38 | 0.33431530 |
| 140 | STK3 | 0.33378313 |
| 141 | TIE1 | 0.33192739 |
| 142 | BRAF | 0.32414956 |
| 143 | ILK | 0.32196051 |
| 144 | MUSK | 0.31967098 |
| 145 | TTK | 0.31861100 |
| 146 | NLK | 0.31466794 |
| 147 | MYLK | 0.31430689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.19661575 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.11157824 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68365997 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.54595192 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.52103194 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.38976675 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.31183879 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.16701775 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.12371778 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.10586898 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.09141803 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.07398323 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.06945530 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.05807615 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.03211813 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.96792624 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94244315 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.90313718 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.85325762 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.81426928 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79350881 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.78430927 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.77142702 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.62056211 |
| 25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57327699 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.57104103 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55199147 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.55088336 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50500395 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.49390998 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47726499 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 1.47436236 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47405557 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43952430 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43730581 |
| 36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.43217612 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41644499 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.40559120 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.38445168 |
| 40 | Bladder cancer_Homo sapiens_hsa05219 | 1.38303057 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37667249 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37654721 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35165948 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.33916901 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33001714 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.31958927 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.31660484 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.31607273 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.30470947 |
| 50 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.27480768 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27122061 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.25310128 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22100689 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21966362 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21630418 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21392016 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20444826 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18449814 |
| 59 | Protein export_Homo sapiens_hsa03060 | 1.17425308 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 1.17161465 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 1.14626996 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12993991 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.12726910 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12295281 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 1.09799015 |
| 66 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.09449340 |
| 67 | Thyroid cancer_Homo sapiens_hsa05216 | 1.08838619 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.08378371 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06628420 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05200396 |
| 71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.04033147 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03757047 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02859191 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02842150 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01799397 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00926514 |
| 77 | Tuberculosis_Homo sapiens_hsa05152 | 0.99150784 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98446758 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.95352030 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.93163127 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92842170 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92597813 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92387772 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92375293 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.91877280 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91375295 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89655120 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89568809 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88074965 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88027842 |
| 91 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.88015088 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.86152780 |
| 93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84968984 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83591786 |
| 95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.82836488 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.81947053 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81739342 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80733340 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80158152 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78805136 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77550502 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76659833 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76370878 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.76115451 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.75189813 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.74583047 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74376048 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73759254 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72584760 |
| 110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72057665 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71984597 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67332133 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66523633 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64158144 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64094853 |
| 116 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63696166 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.62536504 |
| 118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61018082 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59868490 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.58803362 |
| 121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58553975 |
| 122 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58212122 |
| 123 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58108214 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57445314 |
| 125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56944278 |
| 126 | Proteasome_Homo sapiens_hsa03050 | 0.56491407 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55535180 |
| 128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54969115 |
| 129 | Prostate cancer_Homo sapiens_hsa05215 | 0.54013044 |
| 130 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53356327 |
| 131 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52060650 |
| 132 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51768314 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51389229 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50338172 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46139505 |
| 136 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46018834 |
| 137 | Legionellosis_Homo sapiens_hsa05134 | 0.45318871 |
| 138 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43848371 |
| 139 | Malaria_Homo sapiens_hsa05144 | 0.38928236 |
| 140 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.38432451 |
| 141 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.33776154 |
| 142 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33329425 |
| 143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33247049 |
| 144 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.31931347 |
| 145 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.31809486 |
| 146 | Pertussis_Homo sapiens_hsa05133 | 0.31428880 |
| 147 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.31047815 |
| 148 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30768944 |
| 149 | Leishmaniasis_Homo sapiens_hsa05140 | 0.28238991 |
| 150 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24854626 |
| 151 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24807139 |
| 152 | Amoebiasis_Homo sapiens_hsa05146 | 0.24659685 |
| 153 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22732413 |
| 154 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.21600553 |
| 155 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20380219 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20277889 |
| 157 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.18976508 |

